Press release content from Business Wire. The AP news staff was not involved in its creation.
$304.5 Million Worldwide Dilated Cardiomyopathy Therapeutics Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com
December 16, 2020 GMT
DUBLIN (BUSINESS WIRE) Dec 16, 2020
The publisher brings years of research experience to the 6th edition of this report. The 137-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
ADVERTISEMENT
Global Dilated Cardiomyopathy Therapeutics Market to Reach $411.6 Million by 2027
Amid the COVID-19 crisis, the global market for Dilated Cardiomyopathy Therapeutics estimated at US$304.5 Million in the year 2020, is projected to reach a revised size of US$411.6 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.
$304 5 Million Worldwide Dilated Cardiomyopathy Therapeutics Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets com - Press Release digitaljournal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from digitaljournal.com Daily Mail and Mail on Sunday newspapers.
Global Dilated Cardiomyopathy Therapeutics Industry
New York, Dec. 14, 2020 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Global Dilated Cardiomyopathy Therapeutics Industry - https://www.reportlinker.com/p05960610/?utm source=GNW
6 Million by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Aldosterone Antagonists, one of the segments analyzed in the report, is projected to record a 3.7% CAGR and reach US$40.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Angiotensin-Converting Enzyme (ACE) Inhibitors segment is readjusted to a revised 3.4% CAGR for the next 7-year period.